Rising Prevalence Of Urological Disorders Drives Sacral Nerve Stimulation Device Market Growth Driver: Leading Transformation in the Sacral Nerve Stimulation Devices Market in 2025

What Are the Projected Growth and Market Size Trends for the Sacral Nerve Stimulation Devices Market?
The market size for sacral nerve stimulation devices has witnessed significant expansion in the recent past. The market, valued at $1.33 billion in 2024, is projected to escalate to $1.49 billion in 2025 with a robust compound annual growth rate (CAGR) of 11.9%. Factors contributing to this historic growth include an increased incidence of urinary and fecal incontinence, advancements in the field of neuromodulation technology, a growing knowledge of non-surgical treatment alternatives, beneficial reimbursement policies, an aging population, a rise in neurological disorder cases, and elevated healthcare expenditure.

In the coming years, the market size of sacral nerve stimulation devices is projected to experience a considerable surge, reaching $2.31 billion by 2029 with a compound annual growth rate (CAGR) of 11.6%. This growth during the forecast period can be credited to several factors including enhancements in reimbursement policies and increasing acceptance of neuromodulation therapies. Other contributing factors are the rising inclination towards non-invasive or minimally invasive treatment methods, the evolution of sacral nerve stimulation devices, patient and healthcare provider preferences, favorable regulatory conditions, and increasing global healthcare spending. Some key trends to watch during this period include the advancement in the miniaturization and the implantable technologies, further research on sacral nerve stimulation devices, the invention of external sacral nerve stimulation devices, patient education and awareness, regulatory progress, market access, and exploration of spinal cord stimulation or peripheral nerve stimulation.

What Is Driving the Growth Trajectory of the Sacral Nerve Stimulation Devices Market?
The anticipated rise in urological conditions is forecasted to fuel the extension of the sacral nerve stimulation devices market. Urological conditions comprise varying issues impacting the urinary tract, kidneys, bladder, and prostate, with these conditions varying in terms of their duration from acute to chronic durations. The origins of urological disorders can be diverse, impacting both the urinary tract and reproductive organs. Furthermore, lifestyle elements such as inadequate nutrition, dehydration, and insufficient exercise could lead to the formation of kidney stones, a painful disorder that affects the urinary tract. Sacral nerve stimulation devices offer a minimally invasive treatment alternative that can effectively handle urological disorders like urinary and fecal incontinence. Notably, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases, a healthcare firm based in the United States, reported that on average each year 651,446 seniors aged 65 and older (212,875 men and 438,572 women) were freshly diagnosed with any kind of urinary incontinence. Consequently, the projected increase in urological disorders is expected to stimulate the enhancement of the sacral nerve stimulation devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18458&type=smp

Which Leading Companies Are Shaping the Growth of the Sacral Nerve Stimulation Devices Market?
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Livanova, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Nevro Corp., Cala Health, Micro Systems Technologies, Neuspera Medical, EndoStim Inc., InCube Labs, Soterix Medical, Synapse Biomedical Inc, Soin Neuroscience, Nuvectra Corporation, StimGuard LLC, Medzell, General Stim Inc.

What Are the Major Trends Shaping the Sacral Nerve Stimulation Devices Market?
Major businesses in the sacral nerve stimulation devices market are focusing on the creation of advanced products like next-generation sacral neuromodulation devices. The aim is to improve patient results, increase the effectiveness of the device, and lower harmful side effects. Next-generation sacral neuromodulation instruments are state-of-the-art devices that provide better control and efficiency in stimulating sacral nerves. In February 2022, for instance, Medtronic plc, an Ireland-based medical device firm, introduced the InterStim X. This next-generation device, developed for sacral neuromodulation therapy, is used to address conditions like overactive bladder (OAB), chronic fecal incontinence, and non-obstructive urinary retention. InterStim X provides sustained, tailored treatment without the necessity for recharging. The device doesn't require recharging, giving patients over ten years of treatment, thereby improving convenience and adherence.

What Are the Key Segments of the Sacral Nerve Stimulation Devices Market?
The sacral nerve stimulation devices market covered in this report is segmented -

1) By Type: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation
2) By Product: External Sacral Nerve Stimulation (SNS) Devices, Implantable Sacral Nerve Stimulation (SNS) Devices
3) By Age: Pediatrics, Adults, Geriatrics
4) By Application: Urinary Incontinence, Fecal Incontinence, Other Applications
5) By End User: Hospital, Ambulatory Surgical Centers, Specialty Clinics

Subsegments:
1) By Electrical Muscle Stimulation: Surface Electrical Muscle Stimulation, Implantable Electrical Muscle Stimulation
2) By Transcutaneous Electrical Nerve Stimulation: Conventional TENS, Burst Mode TENS, Modulated TENS

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/sacral-nerve-stimulation-devices-global-market-report

Which Region Dominates the Sacral Nerve Stimulation Devices Market?
North America was the largest region in the sacral nerve stimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Sacral Nerve Stimulation Devices Global Market Report?

- Market Size Analysis: Analyze the Sacral Nerve Stimulation Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Sacral Nerve Stimulation Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Sacral Nerve Stimulation Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Sacral Nerve Stimulation Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18458

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.